Hermetica Superfood Encyclopedia
The Short Answer
Carpobrotus edulis leaves and flowers concentrate chlorogenic acid (43.7% of polyphenolic profile), B-type procyanidin oligomers, flavan-3-ols, and O-methylated flavonols that scavenge free radicals, inhibit cholinesterases, and suppress apoptotic cascades via caspase 9 and caspase 3/7 pathways. Preclinical antioxidant assays report DPPH IC50 of 56.19 μg/ml and ABTS IC50 of 58.91 μg/ml, while 30 μM extract pre-treatment in SH-SY5Y neuronal cells attenuated MPP+-induced reactive oxygen species production and reduced nuclear condensation, though no human clinical data yet confirm these effects.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary Keywordikhambi-lamabulawo Carpobrotus edulis benefits
Ikhambi-lamabulawo — botanical close-up
Health Benefits
**Antioxidant Protection**: Leaf and flower extracts achieve DPPH IC50 of 56
19 μg/ml and ABTS IC50 of 58.91 μg/ml, driven primarily by chlorogenic acid and procyanidin oligomers that donate electrons to neutralize reactive oxygen species and break lipid peroxidation chain reactions.
**Sore Throat and Cold Symptom Relief**
In Zulu ethnomedicine, leaf juice or decoctions are applied to the throat to relieve soreness associated with colds, an effect plausibly linked to the antimicrobial and anti-inflammatory phenolic content, though clinical validation in this indication is absent.
**Antibacterial Activity**
Extracts inhibit Gram-positive pathogens including Staphylococcus aureus and Bacillus cereus, with flavonoids and tannins disrupting bacterial cell membrane integrity and interfering with metabolic enzyme function, supporting traditional wound-cleansing applications.
**Wound Healing Support**
Traditional use across South Africa and Tunisia for topical wound treatment is consistent with preclinical evidence of antimicrobial, antioxidant, and anti-apoptotic actions that collectively reduce local infection risk, oxidative tissue damage, and cell death at wound margins.
**Neuroprotective Potential**: At 30 μM, C
edulis extract pre-treatment in MPP+-challenged SH-SY5Y cells reduces caspase 9 initiation and caspase 3/7 execution of apoptosis, lowers ROS accumulation, and decreases Hoechst-stained condensed nuclei, indicating mitochondria-targeted cytoprotection relevant to Parkinson's disease models.
**Cholinesterase Inhibition**
Extracts inhibit both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), enzymes responsible for acetylcholine hydrolysis; this activity, attributed to flavonols and flavan-3-ols, suggests a mechanistic basis for potential cognitive or neuromuscular applications pending further study.
**Anti-apoptotic and Cytoprotective Effects**
Beyond neuronal models, the high flavonoid content (up to 24% w/w in optimized ethanol-water extracts) and phenolic load (up to 24.12% w/w) confer broad cytoprotective effects by reducing mitochondrial stress signals and preserving membrane integrity across multiple cell-based models.
Origin & History
Natural habitat
Carpobrotus edulis is indigenous to the Western Cape of South Africa, where it grows as a mat-forming succulent on coastal dunes, sandy soils, and rocky outcrops, thriving in full sun and salt-tolerant environments. It has been widely naturalized across Mediterranean climates including Tunisia, southern Europe, and California, often classified as an invasive species in these regions. Traditional cultivation is informal; the plant spreads vegetatively and is harvested wild from coastal populations in southern Africa and North Africa.
“Carpobrotus edulis has been integrated into the traditional healing practices of Zulu communities in South Africa, where it is called ikhambi-lamabulawo and the leaf juice is used to relieve sore throats associated with colds and upper respiratory infections. In Tunisia and across North Africa, the plant has an independent ethnobotanical tradition as a topical wound-healing agent, with leaves applied as a poultice or wash to infected or inflamed skin lesions, a use documented in regional ethnopharmacological surveys. The succulent's wide coastal distribution made it accessible to both settled agricultural communities and nomadic groups, embedding it into folk pharmacopeias across two continents before any formal phytochemical investigation. Its Afrikaans common name 'suurvy' (sour fig) and English names 'ice plant' and 'Hottentot fig' reflect the colonial-era documentation of southern African traditional uses, and its edible salty-sour fruits were consumed as food by indigenous communities, distinguishing it from purely medicinal plants.”Traditional Medicine
Scientific Research
The body of evidence for Carpobrotus edulis consists entirely of in vitro biochemical assays, cell-line experiments, and a planarian (Dugesia sicula) regeneration model; no randomized controlled trials or observational human studies have been published as of available data. Antioxidant capacity has been quantified across multiple solvent extract systems with reproducible IC50 values in the 56–59 μg/ml range, providing reasonable phytochemical characterization. The neuroprotection data derive from a single cell-based experiment using MPP+-induced toxicity in SH-SY5Y cells at a fixed 30 μM concentration, with viability confirmed by MTT assay and apoptosis assessed by caspase activity and nuclear staining, representing preliminary mechanistic insight rather than therapeutic proof. Phytochemical profiling studies report flavonoid content of 116.16 ± mg/g and phenolic totals up to 184 ± 5 mg/100 g fresh matter, supporting ingredient characterization, but standardization across preparations, bioavailability in humans, and efficacy in any clinical population remain entirely unestablished.
Preparation & Dosage
Traditional preparation
**Traditional Leaf Juice (Zulu oral/topical)**
Fresh leaves are crushed or chewed, and the expressed juice is gargled or applied directly to the throat; no standardized volume is established, with use guided by traditional practice.
**Aqueous-Acetone Leaf Extract (research grade)**
2 mg/ml; not commercially available in this form and not appropriate for unsupervised human use
Used in antioxidant and planarian studies at concentrations up to .
**Microwave-Assisted Ethanol-Water Extract**
Optimized at 30% ethanol/70% water at a 1:15 plant-to-solvent ratio (m/v), yielding up to 24.12% w/w total phenolics and 23.61% w/w total flavonoids; used in phytochemical characterization research only.
**Cell-Model Concentration**
30 μM extract used in SH-SY5Y neuroprotection experiments; human equivalent dosing has not been calculated or validated.
**No Standardized Commercial Supplement Form**
No capsule, tablet, tincture, or standardized extract product has been described in the scientific literature; dosage recommendations for human supplementation cannot be made from available evidence.
Nutritional Profile
Fresh leaf matter contains approximately 184 ± 5 mg total phenolics per 100 g, with chlorogenic acid constituting 43.7% of the polyphenolic fraction, making it a quantitatively significant dietary source of this hydroxycinnamic acid when consumed. Flavonoid content reaches up to 116.16 ± mg/g dry weight, comprising B-type procyanidin oligomers, dihydroquercetin derivatives, O-methylated flavonols, and flavan-3-ols, with flowers generally richer in these compounds than leaves. Tannins, anthraquinones, and sulphate-containing compounds are preferentially concentrated in leaves rather than flowers, adding to the diverse secondary metabolite profile. Macronutrient composition of the edible fruit includes sugars and water typical of succulent tissue, but precise carbohydrate, protein, and fat values are not reported in pharmacognostic studies; the high water content of succulent tissue implies low caloric density. Bioavailability of phenolics from whole-plant preparations is unknown, as no human pharmacokinetic studies have been conducted.
How It Works
Mechanism of Action
The primary antioxidant mechanism involves chlorogenic acid and procyanidin oligomers donating hydrogen atoms or electrons to DPPH and ABTS radicals, with the catechol moiety of chlorogenic acid being particularly reactive toward peroxyl and hydroxyl radical species, thereby lowering systemic oxidative burden. In neuronal SH-SY5Y cells, 30 μM extract pre-treatment before MPP+ exposure suppresses mitochondrial outer membrane permeabilization, preventing cytochrome c release and subsequent activation of the intrinsic apoptotic pathway, measured as reduced caspase 9 cleavage and downstream caspase 3/7 activity; Hoechst 33342 staining confirms fewer cells with condensed, apoptotic nuclei. Antibacterial activity against Staphylococcus aureus and Bacillus cereus is attributed to phenolic disruption of cell membrane fluidity and inhibition of bacterial DNA gyrase and cell wall biosynthesis enzymes. Cholinesterase inhibition by flavonols and flavan-3-ols occurs through competitive or mixed-mode binding at the catalytic anionic site of AChE and BuChE, prolonging synaptic acetylcholine availability and suggesting indirect cholinomimetic effects.
Clinical Evidence
No human clinical trials investigating Carpobrotus edulis or ikhambi-lamabulawo for any indication have been identified in the available literature. The totality of intervention evidence comes from in vitro radical-scavenging assays, SH-SY5Y cell culture models of Parkinson's-like toxicity, and invertebrate (planarian) regeneration studies, none of which constitute clinical evidence. Effect sizes measured in cell models — such as statistically significant reductions in caspase 3/7 activity at 30 μM — are biologically plausible but cannot be extrapolated to effective human doses without pharmacokinetic and bioavailability studies. Confidence in clinical benefit for any specific indication, including the traditional Zulu use for sore throat relief, is currently low and dependent on future first-in-human studies.
Safety & Interactions
In planarian (Dugesia sicula) regeneration models, non-toxic concentrations of C. edulis extract permitted normal morphological regeneration, while higher concentrations induced measurable morphological alterations, suggesting a dose-dependent safety threshold that has not been defined for mammalian or human biology. No human adverse event data, maximum tolerated doses, or systematic toxicology studies are available, meaning the safety profile in clinical contexts is entirely uncharacterized. No drug interactions have been formally studied; however, the documented inhibition of acetylcholinesterase and butyrylcholinesterase raises a theoretical interaction risk with cholinesterase-inhibitor medications (e.g., donepezil, rivastigmine) and anticholinergic drugs, warranting caution until interaction studies are conducted. Guidance for use during pregnancy and lactation cannot be provided due to the complete absence of reproductive toxicology data, and use in these populations should be avoided until safety is established.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Carpobrotus edulisSuurvyHottentot figIce plantSour figIgcukuma (alternate Zulu name)
Frequently Asked Questions
What is ikhambi-lamabulawo used for in traditional Zulu medicine?
In Zulu traditional medicine, ikhambi-lamabulawo (Carpobrotus edulis) is primarily used to relieve sore throats associated with colds, typically by gargling or applying the expressed juice from crushed fresh leaves directly to the throat. This application is supported plausibly by the plant's documented antimicrobial activity against Gram-positive bacteria and its high phenolic content, though no controlled clinical studies have confirmed efficacy in this specific indication.
What are the main bioactive compounds in Carpobrotus edulis?
The principal bioactive compounds in Carpobrotus edulis are chlorogenic acid (43.7% of the polyphenolic profile in aqueous-acetone leaf extracts), B-type procyanidin oligomers, dihydroquercetin derivatives, O-methylated flavonols, flavan-3-ols, and proanthocyanidins. Optimized ethanol-water extracts contain up to 24.12% w/w total phenolics and up to 23.61% w/w total flavonoids, with flowers generally richer in most phytochemical classes except tannins and anthraquinones, which concentrate in leaves.
Is there clinical trial evidence supporting Carpobrotus edulis health benefits?
No human clinical trials for Carpobrotus edulis have been published; all available intervention evidence derives from in vitro radical-scavenging assays, SH-SY5Y neuronal cell culture experiments at 30 μM concentration, and invertebrate planarian regeneration models. While these preclinical results — including DPPH IC50 of 56.19 μg/ml and significant caspase 3/7 reduction in neuroprotection models — are biologically interesting, they cannot be directly translated to human therapeutic recommendations without first-in-human pharmacokinetic and safety studies.
Is Carpobrotus edulis safe to consume or use medicinally?
The safety profile of Carpobrotus edulis in humans is currently uncharacterized, as no formal toxicology studies, maximum tolerated dose assessments, or adverse event reporting exists for human use. Planarian models show that high extract concentrations cause morphological abnormalities, indicating a dose-dependent risk threshold that has not been defined for mammals. People taking cholinesterase inhibitors (such as donepezil or rivastigmine) or anticholinergic medications should exercise particular caution given the plant's documented AChE and BuChE inhibitory activity.
How is Carpobrotus edulis extract prepared for research or traditional use?
Research preparations use aqueous-acetone or microwave-assisted ethanol-water extraction, with an optimized ratio of 30% ethanol to 70% water at 1:15 plant-to-solvent mass-to-volume ratio yielding the highest phenolic and flavonoid concentrations. Traditional Zulu preparation is far simpler: fresh leaves are crushed or directly bitten to release the juice, which is then applied to or gargled against the throat. No commercially standardized supplement form (capsule, tincture, or tablet) currently exists based on available scientific literature.
What is the difference between Carpobrotus edulis leaf extract and flower extract for antioxidant benefits?
Both leaf and flower extracts of Carpobrotus edulis demonstrate strong antioxidant capacity, with leaf extracts achieving a DPPH IC50 of 56.19 μg/ml and flower extracts reaching 58.91 μg/ml (ABTS assay). The antioxidant potency in both forms is driven by chlorogenic acid and procyanidin oligomers, which neutralize reactive oxygen species and prevent lipid peroxidation chain reactions. Leaf extracts are traditionally more commonly used in Zulu medicine, though flower extracts offer comparable antioxidant power for research and supplemental applications.
How should Carpobrotus edulis be consumed for sore throat and cold symptom relief—juice, decoction, or extract?
Traditional Zulu medicine employs both leaf juice and decoctions applied directly to the throat for symptom relief, reflecting preparation methods optimized for local delivery and traditional efficacy. Modern supplemental forms may include concentrated extracts, though the traditional liquid preparations (juice or decoction) allow for topical application that may maximize contact with affected tissues. The choice between forms depends on intended use—topical application favors juice or decoction, while systemic antioxidant support may benefit from standardized extracts with documented bioactive compound concentrations.
Which populations are best suited to use Carpobrotus edulis supplements for antioxidant protection?
Individuals seeking natural antioxidant support from plant sources with documented DPPH and ABTS activity may benefit from Carpobrotus edulis, particularly those interested in traditional Southern African ethnobotanical approaches. The ingredient's chlorogenic acid and procyanidin oligomer content positions it as suitable for adults concerned with oxidative stress reduction, though specific population recommendations require further clinical validation. Those with existing sore throat or cold symptoms may find traditional juice or decoction forms particularly relevant, based on established Zulu medicinal use patterns.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w ikhambi-lamabulawo-carpobrotus-edulis curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
